» Articles » PMID: 5309084

Advances in Techniques of Testing Mycobacterial Drug Sensitivity, and the Use of Sensitivity Tests in Tuberculosis Control Programmes

Overview
Specialty Public Health
Date 1969 Jan 1
PMID 5309084
Citations 254
Authors
Affiliations
Soon will be listed here.
Abstract

In a paper arising out of an informal international consultation of specialists in the bacteriology of tuberculosis held in 1961, an attempt was made to formulate criteria, and specify technical procedures, for reliable tests of sensitivity (the absolute-concentration method, the resistance-ratio method and the proportion method) to the 3 main antituberculosis drugs (isoniazid, streptomycin and p-aminosalicylic acid). Seven years later, a further consultation was held to review the latest developments in the field and to suggest how sensitivity tests might be put to practical use in tuberculosis control programmes. The participants reached agreement on how to define drug sensitivity and resistance, and stressed the importance of using a discrimination approach to the calibration of sensitivity tests. Their views are contained in the present paper, which also includes descriptions of the sensitivity tests used by the Medical Research Council of Great Britain for first- and second-line drugs (minimal inhibitory concentration and resistance-ratio methods), the two main variants of the proportion method developed by the Institut Pasteur, Paris, and a method for calibrating sensitivity tests.

Citing Articles

Comparisons of genome assembly tools for characterization of genomes using hybrid sequencing technologies.

Trisakul K, Hinwan Y, Eisiri J, Salao K, Chaiprasert A, Kamolwat P PeerJ. 2024; 12:e17964.

PMID: 39221271 PMC: 11366230. DOI: 10.7717/peerj.17964.


Targeted next-generation sequencing of from patient samples: lessons learned from high drug-resistant burden clinical settings in Bangladesh.

Khaja Mafij Uddin M, Cabibbe A, Nasrin R, Ghodousi A, Nobel F, Rahman S Emerg Microbes Infect. 2024; 13(1):2392656.

PMID: 39136526 PMC: 11348811. DOI: 10.1080/22221751.2024.2392656.


Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trial.

Hissar S, Velayutham B, Tamizhselvan M, Rathinam S, Arunbabu C, Vidhya J BMC Infect Dis. 2024; 24(1):729.

PMID: 39054415 PMC: 11270935. DOI: 10.1186/s12879-024-09511-w.


Multidrug-resistant Mycobacterium tuberculosis transmission in Shandong, China.

Li Y, Li Y, Wang T, Li Y, Tao N, Kong X Medicine (Baltimore). 2024; 103(12):e37617.

PMID: 38518003 PMC: 10956945. DOI: 10.1097/MD.0000000000037617.


Targeted genome sequencing for tuberculosis drug susceptibility testing in South Africa: a proposed diagnostic pipeline.

Bagratee T, Studholme D Access Microbiol. 2024; 6(2).

PMID: 38482355 PMC: 10928400. DOI: 10.1099/acmi.0.000740.v3.


References
1.
CANETTI G . Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965; 92(5):687-703. DOI: 10.1164/arrd.1965.92.5.687. View

2.
Bartmann K . Towards an international standardization of resistance tests on mycobacteria. Scand J Respir Dis. 1968; 49(2):141-52. View

3.
CANETTI G, Kreis B, THIBIER R, Gay P, Le Lirzin M . [Current data on primary resistance in pulmonary tuberculosis in adults in France. 2d survey of the Centre d'Etudes sur la Resistance Primaire: 1965-1966]. Rev Tuberc Pneumol (Paris). 1967; 31(4):433-74. View

4.
Thomas K, Joseph S, SUBBAIAH T, Selkon J . Identification of tubercle bacilli from Indian patients with pulmonary tuberculosis. Bull World Health Organ. 1961; 25:747-58. PMC: 2555626. View

5.
CANETTI G, RIST N, Grosset J . [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation]. Rev Tuberc Pneumol (Paris). 1963; 27:217-72. View